Key result
Depression shows no association with nutritional status or inflammatory markers in peritoneal dialysis patients.
Why the study?
Does antidepressant treatment improve nutritional status and inflammatory markers in peritoneal dialysis patients with depression?
Observational (n=60)
Does antidepressant treatment improve nutritional status and inflammatory markers in peritoneal dialysis patients with depression?
Depression is common in peritoneal dialysis patients but its treatment with antidepressants does not appear to improve nutritional status or reduce inflammation.
Answers are grounded in this paper and cite their sources.
Depression in PD patients shows no nutritional or inflammatory effects; observational data leaves open whether screening or treatment alters outcomes.
BACKGROUND: To investigate the relationship between depression, nutritional status, and inflammatory markers in patients on peritoneal dialysis (PD). PATIENTS AND METHODS: This prospective study included 40 PD patients and 20 healthy people. The severity of depressive symptoms was assessed using the Beck depression inventory, the Hamilton depression rating scale, and the Hamilton anxiety rating scale. The depressive patients received antidepressant drug for 8 weeks. Blood samples were taken before and after antidepressant treatment for the high-sensitive C-reactive protein (hs-CRP), interleukin (IL)-1, IL-6, and tumor necrosis factor-α (TNF-α) levels. RESULTS: Ten (25%) of the 40 PD patients had depression. No significant difference was determined between depressive patients and nondepressive patients. The mean erythrocyte sedimentation rate was higher in depressive patients. There was no significant difference for other inflammation parameters, including hs-CRP, TNF-α, IL-1, and IL-6, between depressive patients and nondepressive patients. In the depressive patients, we did not observe any significant change in nutritional parameters after antidepressant treatment. When we evaluated inflammation parameters of the depressive patients before and after antidepressant treatment, only IL-1 and IL-6 levels were significantly increased after antidepressant treatment. CONCLUSION: The depressive disorder in PD patients is a common psychopathology and has no significant effects on nutritional status and inflammation.
No takes yet. Share an insight, caveat, or question.
Cilan et al. (2012) conducted an observational in Peritoneal dialysis and depression (n=60). Depression vs. Nondepressive patients was evaluated on Nutritional status and inflammatory markers (hs-CRP, TNF-α, IL-1, IL-6). Depression affected 25% (10 of 40) of peritoneal dialysis patients and showed no significant association with nutritional status or inflammatory markers compared to nondepressive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: